Thus, we speculate that the interaction of CCR6 and CCL18 might be pivotal for the progress of IPF, whereas in fibrosis, due to sarcoidosis or HP, these processes are obviously driven by other factors. The gene discussed is CCL18; the disease is fibrosis.